Clinical Drug Review & Program Administration

This subcontract opportunity with the New York State Department of Health involves providing clinical oversight and administration for the Medicaid Fee-for-Service Pharmacy Benefit Management program. The selected provider will be responsible for operating the Clinical Drug Review Program and the Preferred Drug Program by evaluating the safety, efficacy, and cost-effectiveness of medications to determine their formulary placement. The role requires specialized expertise in pharmacoeconomics, clinical pharmacy, and Medicaid regulatory compliance to ensure all operations meet state standards. Key deliverables include the management and submission of Clinical Drug Review and Preferred Drug Program reports. Interested parties must respond by December 8, 2026.